Minocycline affects human neutrophil respiratory burst and transendothelial migration

Inflamm Res. 2017 Feb;66(2):107-109. doi: 10.1007/s00011-016-0999-x. Epub 2016 Oct 18.

Abstract

Objective: This study aimed at investigating the in vitro activity of minocycline and doxycycline on human polymorphonuclear (h-PMN) cell function.

Methods: h-PMNs were isolated from whole venous blood of healthy subjects; PMN oxidative burst was measured by monitoring ROS-induced oxidation of luminol and transendothelial migration was studied by measuring PMN migration through a monolayer of human umbilical vein endothelial cells. Differences between multiple groups were determined by ANOVA followed by Tukey's multiple comparison test; Student's t test for unpaired data for two groups.

Results: Minocycline (1-300 µM) concentration dependently and significantly inhibited oxidative burst of h-PMNs stimulated with 100 nM fMLP. Ten micromolar concentrations, which are superimposable to C max following a standard oral dose of minocycline, promoted a 29.8 ± 4 % inhibition of respiratory burst (P < 0.001; n = 6). Doxycycline inhibited ROS production with a lesser extent and at higher concentrations. 10-100 µM minocycline impaired PMN transendothelial migration, with maximal effect at 100 µM (42.5 ± 7 %, inhibition, n = 5, P < 0.001).

Conclusions: These results added new insight into anti-inflammatory effects of minocycline exerted on innate immune h-PMN cell function.

Keywords: Inflammation; Minocycline; Neutrophils; ROS; Transendothelial migration.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Inflammatory Agents / pharmacology*
  • Cells, Cultured
  • Doxycycline / pharmacology
  • Humans
  • Minocycline / pharmacology*
  • Neutrophils / drug effects*
  • Neutrophils / metabolism
  • Neutrophils / physiology
  • Reactive Oxygen Species / metabolism
  • Respiratory Burst / drug effects
  • Transendothelial and Transepithelial Migration / drug effects

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Reactive Oxygen Species
  • Minocycline
  • Doxycycline